March 2015 FDA Recall Glipizide And Metformin Hcl by Heritage Pharmaceuticals, Inc.
D-0436-2015 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Heritage Pharmaceuticals, Inc. on March 25, 2015 for the product Glipizide And Metformin Hcl. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0436-2015

Reason for Recall
Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
Initiated
03-25-2015
Reported
04-15-2015
Quantity
6,816 Bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Heritage Pharmaceuticals, Inc.
U.S. Nationwide including Puerto Rico.
GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets, USP, 2.5 mg/500 mg, 100 ct Bottles, Rx Only. Manufactured for: Heritage Pharmaceuticals Inc. Eatontown, NJ 07724, NDC: 23155-116-01.

Batch or Lot Expiration Information

Lot# :18020994, Expiry: October 2015
Lot# : 18021311, Expiry: November 2015.